Chinese medicine yinpian industry accelerated the transformation: the future development of focusing on three key words

Medical network

The 2016-09-18

Medical network - on September 14, recently, traditional Chinese medicine in China association of professional committee of the Chinese medicine yinpian, and jointly organized by bozhou city pharmaceutical development council, bozhou city of Chinese medicine yinpian industry association to undertake "BBS" in 2016, Chinese medicine yinpian industry development, from the state administration of traditional Chinese medicine, Chinese traditional Chinese medicine association, henan university of traditional Chinese medicine and other units of the experts and leaders think, Chinese medicine yinpian industry is accelerating transformation, specification, innovation, and focus on is the future development of Chinese medicine yinpian industry keywords.

Status quo of the five characteristics

Since 2004, according to China association of traditional Chinese medicine, Chinese medicine yinpian industry overall growth rate over 30%, considerably more than the pharmaceutical industry as a whole the average growth rate. In 2015 sales revenue of 170 billion yuan, Chinese medicine yinpian industry by 2016, Chinese medicine yinpian market demand will reach 200 billion yuan, in 2020 to the market demand is expected to exceed 350 billion yuan. The support of national policy guidance for Chinese medicine yinpian industrial upgrading to bring more development space, but at the same time slices industry also faces challenges.

In general, at present, the Chinese medicine yinpian industry presents the five features:

Is a production enterprise scale small and scattered. Compared with the traditional industry, Chinese medicine yinpian industry started late, on a smaller scale as a whole. According to authoritative data, until the end of June, 2016 through the new GMP certification of Chinese medicine yinpian enterprise 1602, enterprises generally small and scattered, causing a disorderly market competition condition.

The second is the product production concentration is low. So far, Chinese medicine yinpian specialization degree and the species concentration is not high, the lack of brand and characteristic. Existing yinpian backward production technology equipment, don't meet the need of modern Chinese medicine industry scale, standardized production. Each yinpian enterprise hospital products each year 600 ~ 800 kinds of specifications, the slices inspection burden heavier.

Three is the slow progress legalized management. Drugadministration law according to the provisions of article 31 of the "approval number management of varieties of traditional Chinese medicine, Chinese medicine yinpian directory by the pharmaceutical supervisory and administrative department under the state council jointly with the administrative department of traditional Chinese medicine of the state council." But not yet implemented. Currently around yinpian enterprise looked forward to the relevant state departments issued related technical regulations as soon as possible. By 2010, the state shall implement a Chinese medicine yinpian has approval of management with artificial bezoar, indigo naturalis, borneol, south star of divine comedy, bravery, donkey-hide gelatin, 20 varieties. It is understood that the current management of these varieties real did not reach the designated position. No approval number of donkey-hide gelatin, etc. Chinese medicine yinpian enterprise production has reached the extent of the flood, Chinese medicine yinpian quality not guaranteed.

Four is a key production technology, lack of protection of intellectual property rights. In recent years, although our country related policy, Chinese medicine yinpian enterprise is unable to foreign joint venture, but as a result of Chinese medicine yinpian processing key technology of academic exchanges, paper, or even in shenzhen, the Japanese jin i. factory of Chinese medicine yinpian, caused the Chinese medicine yinpian processing technology of leakage and the loss of intellectual property rights.

Five is the product quality problems. Due to the Chinese medicine yinpian quality cannot be guaranteed to obtain the very good, "on the certificate, party, disease, drug" phenomenon is relatively common, affects the sustained, rapid and healthy development of the industry. The cause of the low quality of Chinese medicine yinpian except Chinese medicine yinpian processing technology specification, quality standard is not sound, the principle is not clear, the lack of traditional processing technology is one of the key factors affecting the quality of Chinese medicine yinpian.

From chaos to treat in the future

Future want to steady development, Chinese medicine yinpian industry must be completed from chaos to shift, it needs the joint efforts of management departments and enterprises. Specification, focus, innovation will lead the Chinese medicine yinpian industry development.

Experts point out that the future of yinpian industry will become increasingly standardized management and norms. At present our country except for some need to strengthen the management and the scientific research foundation of good varieties, such as rhubarb, red sage root, indigo naturalis shall manage the approval number 70 kinds of Chinese medicine yinpian pilot, not the number of the approval document for the full implementation of Chinese medicine yinpian management system, the future will be to develop in the direction of drug approval document management, has not obtained approval number of varieties, Chinese medicine yinpian enterprise will not be able to reproduce these slices varieties. In the aspect of Chinese medicine yinpian standard, our country not only in yinpian processing on the lack of unified standards, and long-term absence in yinpian quality control standards. Processing method has a great influence on the quality and curative effect of Chinese medicine yinpian, but according to statistics, at present, clear up in Chinese pharmacopoeia standard accounted for only 2.7% of the total medicinal herbs, and the reference to various provinces and cities specified in pharmacopoeia, no local regulations, but around Chinese medicine yinpian processing technology of diversity, some very different, even conflicting, this leads to the curative effect of Chinese medicine yinpian quality of final product and local differences, Chinese medicine yinpian benign development.

In addition, Chinese medicine yinpian quality evaluation of the long-term use of appearance, color, odor, moisture and other relatively simple apparent evaluation standard, lack of key active ingredients, such as pesticide residues, heavy metals and harmful composition detection quantitative evaluation standard, it is also one of the factors hinder the healthy development of Chinese medicine yinpian. At present, some industry leading enterprises begin to pay attention to the quality of Chinese medicine yinpian quantitative evaluation, such as ChengShi grass bouquet and so on to build industry leading testing center, use all kinds of chromatography, atomic absorption tools such as Chinese medicine yinpian quality quantitative evaluation.

China's traditional Chinese medicine association of professional committee of the Chinese herbal medicine seed seedlings run-huai zhao pointed out on the BBS, for Chinese medicine yinpian enterprise, the most important thing is to deal in Taiwan, do back, the tree brand. China association of traditional Chinese medicine expert yu-zhen ren believed that Chinese medicine yinpian enterprise want to become bigger and stronger, the first thing to improve market share, the property characteristics of medicinal materials should implement trademark protection and patent protection, protection measures for the protection of new drugs, positive change Chinese medicine yinpian existing production mode, walk the road of big business, big variety, large market, and strive to become the leading enterprises. Chinese medicine yinpian industry in China has been developing for thousands of years, but the real start of industrialization is not a long time, although there are a lot of Chinese medicine yinpian enterprise in the industry, but there is no real advantage leading enterprises, mergers and reorganization will be a trend in the future.

From the point of dosage forms, traditional Chinese medicine yinpian native medicine use, need to be boiled decoction, time-consuming, and is used for patients with inadequate and inconvenient to carry, use effective components problem. In recent years, with traditional Chinese medicine (TCM) formula particles and ultra-fine slices (wall-breaking yinpian) as the representative of new yinpian adapt to consumer demand, usher in rapid development, the new Chinese medicine yinpian alternative space of traditional Chinese medicine yinpian have larger. TCM formula granules in China in recent years the rapid growth in sales revenue, according to foresight network data, sales revenue growth from 230 million yuan in 2006 to 2014, about 6.5 billion yuan, annual compound growth rate of 52%, the proportion of traditional Chinese medicine formula particles in Chinese medicine yinpian also increase from 1.2% to 1.2%, in 2016 is expected to exceed ten billion yuan. Superfine slices is the third generation of slices, refers to the use of superfine powder technology Chinese medicine yinpian shattered into 1 microns to 75 microns superfine powder, the medicinal plant cell wall broken rate increase, is beneficial to its effective ingredient dissolution, increase the specific surface area, increase the absorption rate and absorption, to use modern type granulating technology made of granular yinpian, mainly used for clinical prescription of traditional Chinese medicine. Superfine yinpian compared to traditional Chinese medicine yinpian, not only avoid Fried, convenient use, and because the drug wall-breaking release effective ingredients, and improve the effectiveness.